BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin S, Yang S, Luo Y, Lu J, Hu G, Wang K, Shao Y, Zhou S, Koo S, Qiu Y, Wang T, Yu H. Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma. Biochem Pharmacol 2021;193:114806. [PMID: 34673013 DOI: 10.1016/j.bcp.2021.114806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Li J, He T, Song Y, Wu J, Wang B. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis. Genes (Basel) 2022;13. [PMID: 36553600 DOI: 10.3390/genes13122331] [Reference Citation Analysis]
2 Yao J, Ma C, Feng K, Tan G, Wen Q. Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective. Biomolecules 2022;12:1565. [DOI: 10.3390/biom12111565] [Reference Citation Analysis]
3 Gao S, Jiang X, Wang L, Jiang S, Luo H, Chen Y, Peng C. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Front Pharmacol 2022;13:1029601. [DOI: 10.3389/fphar.2022.1029601] [Reference Citation Analysis]
4 Wang J, Miao Y, Li L, Wu Y, Ren Y, Cui Y, Cao H. Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning. Front Genet 2022;13:962870. [DOI: 10.3389/fgene.2022.962870] [Reference Citation Analysis]
5 Lv F, Li X, Wang Y. Lycorine inhibits angiogenesis by docking to PDGFRα. BMC Cancer 2022;22:873. [PMID: 35948939 DOI: 10.1186/s12885-022-09929-y] [Reference Citation Analysis]
6 Javed A, Malagraba G, Yarmohammadi M, Perelló-reus CM, Barceló C, Rubio-tomás T. Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System. Future Pharmacology 2022;2:214-237. [DOI: 10.3390/futurepharmacol2030015] [Reference Citation Analysis]
7 Regmi P, He Z, Lia T, Paudyal A, Li F. N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma. Front Genet 2022;13:918983. [DOI: 10.3389/fgene.2022.918983] [Reference Citation Analysis]